Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CGEM stock hub

Cullinan Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CGEMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

894.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CGEM

In the news

Latest news · CGEM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-48.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-957.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CGEM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001789972
Company name	Cullinan Therapeutics, Inc.
Country	United States
Country code	US
Cusip	230031106
Employees	109
Employees Change	-2%
Employees Change Percent	-1.8
Enterprise value	$544.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-01-08
Isin	US2300311063
Last refreshed	2026-05-10
Market cap	$894.2M
Market cap category	Small-Cap
Price	$14.55
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	CGEM
Website	https://cullinantherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.72%
FCF yield	-19.98%
P/B ratio	2.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-221M
Net Income Growth Years	0%
Profit Per Employee	$-2M
ROA	-30.57
Roa5y	-20.57
ROCE	-65.34
ROE	-48.16
Roe5y	-21.26
ROIC	-957.8
Roic5y	-245.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	89.04%
Cagr3y	14.94%
Cagr5y	-13.39%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$403M
Cash	$351.9M
Current Assets	$361.4M
Current Liabilities	$35.2M
Debt	$2.4M
Debt Equity	$0.01
Equity	$366.2M
Liabilities	$36.8M
Long Term Assets	$41.6M
Long Term Liabilities	$1.7M
Net Cash	$349.5M
Net Cash By Market Cap	$39.08
Net Cash Growth	15.73%
Net Debt Equity	$-0.95
Tangible Book Value	$366.2M
Tangible Book Value Per Share	$5.96
WACC	3.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.28
Net Working Capital	$-24.9M
Quick ratio	10.01
Working Capital	$326.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.94%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	88.96%
200-day SMA	10.46
3Y total return	51.88%
50-day SMA	14.26
50-day SMA vs 200-day SMA	50over200
5Y total return	-51.27%
All Time High	59.85
All Time High Change	-75.69%
All Time High Date	2021-03-10
All Time Low	5.68
All Time Low Change	156.16%
All Time Low Date	2025-10-03
ATR	0.97
Beta	-0.09
Beta1y	0.85
Beta2y	0.75
Ch YTD	40.58
High	15.2
High52	16.74
High52 Date	2026-02-27
High52ch	-13.08%
Low	14.3
Low52	5.68
Low52 Date	2025-10-03
Low52ch	156.16%
Ma50ch	2.06%
Premarket Change Percent	-1.49
Premarket Price	$14.5
Premarket Volume	1,606
Price vs 200-day SMA	39.15%
RSI	54.06
RSI Monthly	54.24
RSI Weekly	59.34
Sharpe ratio	1.14x
Sortino ratio	2.14
Total Return	-2.94%
Tr YTD	40.58
Tr1m	-2.09%
Tr1w	8.34%
Tr3m	18.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	5
Analyst Price Target Top	$29.6
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.84
Earnings Revenue Estimate	3,468,000x
Operating Income	$-240.3M
Price target	$30.25
Price Target Change	$108
Price Target Change Top	$103

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44,266,083%
Float Percent	72.03%
Shares Insiders	1.09%
Shares Institutions	76.49%
Shares Out	61,458,046
Shares Qo Q	2.13%
Shares Yo Y	2.94%
Short Float	18.33%
Short Ratio	9.52
Short Shares	13.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-213M
Average Volume	795,039.4x
Bv Per Share	5.96
CAPEX	$-49,000
Ch1m	-2.09
Ch1w	8.34
Ch1y	88.96
Ch3m	18.97
Ch3y	51.88
Ch5y	-51.27
Ch6m	102.4
Change	-1.15%
Change From Open	-0.41
Close	14.72
Days Gap	-0.75
Depreciation Amortization	314,000
Dollar Volume	9,095,830.7
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-240.3M
EBITDA	$-240M
EPS	$-3.73
F Score	1
FCF	$-178.7M
FCF EV Yield	-32.8x
FCF Per Share	$-2.91
Financing CF	1,468,000
Fiscal Year End	December
Founded	2,016
Investing CF	175,598,000
Ipr	-30.71
Iprfo	-65.36
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	11.56
Ma150ch	25.84%
Ma20	14.1
Ma20ch	3.18%
Net CF	-1,574,000
Next Earnings Date	2026-08-06
Open	14.61
Optionable	Yes
Position In Range	27.78
Post Close	14.55
Postmarket Change Percent	0.07
Postmarket Price	$14.56
Ppne	2,779,000
Pre Close	14.72
Price Date	2026-05-08
Ptbv Ratio	2.44
Relative Volume	0.79x
Share Based Comp	34,282,000
Tr6m	102.36%
Us State	Massachusetts
Volume	625,143

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CGEM pay a dividend?

Capital-return profile for this ticker.

Performance

CGEM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CGEM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.5%

Float: +72.0% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CGEM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.1

Neutral momentum band

Price vs 200-day MA

+39.2%

50/200-day relationship not available

Beta (5Y)

-0.09

Less volatile than the market

Sharpe ratio

1.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CGEM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CGEM stock rating?

Cullinan Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CGEM analysis?

The full report lives at /stocks/CGEM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CGEM?

The latest report frames CGEM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CGEM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.